Vyant Bio, Inc. Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive Loss

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Revenue:
Service
Product
Total revenue
Cost of revenues
Gross profit
Operating costs and expenses:
General and administrative
Cost of goods sold – product
Service
Product
Research and Development Expense
Selling, general and administrative
Restructuring costs
Impairment of goodwill
Impairment of intangible assets
Merger related costs
Total operating costs and expenses
Loss from operations
Other income (expense):
Interest expense
Interest income
Change in fair value of acquisition note payable
Other expense

Change in fair value of warrant liability
Change in fair value of share-settlement obligation derivative
Change in fair value of siParadigm Earn-Out
Change in fair value of Excess Consideration Note
Loss on debt conversions
Other income
Interest expense, net
Total other income (expense)

Loss before income taxes
Loss from continuing operations before income taxes
Income tax expense (benefit)
Loss from continuing operations
Discontinuing operations (net of ($21) and $0 tax (benefit) expense in 2022 and 2021, respectively)
Net loss
Cumulative translation adjustment
Comprehensive loss
Net loss per share from continuing operations
Basic and diluted net income (loss) per share from discontinuing operations (usd per share)
Net loss per share from discontinuing operations
Net loss per share
Weighted average common shares outstanding – basic and diluted
Net loss per share attributed to common stock – basic and diluted:
Net loss per share from continuing operations
Net loss per share from discontinuing operations
Net loss per share
Weighted average common shares outstanding – basic and diluted

Comments